CRP, PCT Added to MELD Ups Prediction of Mortality in Cirrhosis

This article originally appeared here.
Share this content:
CRP, PCT Added to MELD Ups Prediction of Mortality in Cirrhosis
CRP, PCT Added to MELD Ups Prediction of Mortality in Cirrhosis

TUESDAY, Sept. 5, 2017 (HealthDay News) -- For patients with cirrhosis, addition of C-reactive protein (CRP) and/or procalcitonin (PCT) to the model for end-stage liver disease (MELD) score improves prediction of mortality, according to a study published online Aug. 25 in the Journal of Gastroenterology and Hepatology.

Sakkarin Chirapongsathorn, M.D., from the Royal Thai Army in Bangkok, and colleagues conducted a prospective study involving consecutive patients admitted with complications of cirrhosis. Patients had venous CRP, PCT, and laboratory values for MELD score calculation measured at the emergency department or admission. The MELD-CRP score was validated externally in 818 patients from Mayo Clinic using data from 1,288 patients with cirrhosis.

The researchers found that 177 patients were admitted during the study period, and 71 were eligible for analysis. The MELD score predicted 90-day mortality (odds ratio, 1.19). Adding CRP or PCT to the MELD score improved 90-day mortality prediction (MELD-CRP: odds ratio, 2.71; MELD-PCT: odds ratio, 2.72; and MELD-CRP-PCT: odds ratio, 2.71). For MELD, MELD-CRP, MELD-PCT, and MELD-CRP-PCT, the C-statistics were 0.81, 0.83, 0.84, and 0.85, respectively. Thirty-day mortality prediction was also improved by adding CRP and/or PCT to the MELD score. For the MELD-CRP score, results were similar for the Mayo Clinic external validation cohort.

"The MELD-CRP, MELD-PCT, and MELD-CRP-PCT scores may be superior to the MELD score alone in predicting mortality in patients hospitalized with complications of cirrhosis," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

From pre- to post-expansion period, 59 percent relative increase in Medicaid-covered preemptive listings

BCG Vaccine Tied to Reduced Hyperglycemia in Type 1 Diabetes

BCG Vaccine Tied to Reduced Hyperglycemia in Type ...

Systemic shift in glucose metabolism from oxidative phosphorylation to aerobic glycolysis

Many Physicians Not Prepared for End-of-Life Talks With Patients

Many Physicians Not Prepared for End-of-Life Talks With ...

Additional training, reimbursement may foster these critical conversations, authors say

is free, fast, and customized just for you!




Already a member?

Sign In Now »